Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway

Afeez Adekunle Ishola, Chian Shiu Chien, Yi Ping Yang, Yueh Chien, Aliaksandr A. Yarmishyn, Ping Hsing Tsai, Jerry Chieh Yu Chen, Po Kuei Hsu, Yung Hung Luo, Yuh Min Chen, Kung Hou Liang, Yuan Tzu Lan, Teh Ia Huo, Hsin I. Ma, Ming Teh Chen, Mong Lien Wang*, Shih-Hwa Chiou


研究成果: Article同行評審

35 引文 斯高帕斯(Scopus)


Lung cancers are the leading cause of cancer-related mortality worldwide, and the majority of lung cancers are non-small cell lung carcinoma (NSCLC). Overexpressed or activated EGFR has been associated with a poor prognosis inNSCLC.Wepreviously identified a circular noncoding RNA, hsa_circ_0000190 (C190), as a negative prognostic biomarker of lung cancer. Here, we attempted to dissect the mechanistic function of C190 and test the potential of C190 as a therapeutic target in NSCLC. C190 was upregulated in both NSCLC clinical samples and cell lines. Activation of the EGFR pathway increased C190 expression through aMAPK/ERK-dependent mechanism. Transient and stable overexpression of C190 induced ERK1/2 phosphorylation, proliferation, and migration in vitro and xenograft tumor growth in vivo. RNA sequencing and Expression2Kinases (X2K) analysis indicated that kinases associated with cell-cycle and global translation are involved in C190-activated networks, including CDKs and p70S6K, which were further validated by immunoblotting. CRISPR/Cas13a-mediated knockdown of C190 decreased proliferation and migration of NSCLC cells in vitro and suppressed tumor growth in vivo. TargetScan and CircInteractome databases predicted that C190 targets CDKs by sponging miR-142-5p. Analysis of clinical lung cancer samples showed that C190, CDK1, and CDK6 expressions were significantly higher in advanced-stage lung cancer than in early-stage lung cancer. In summary, C190 is directly involved in EGFR- MAPK-ERK signaling and may serve as a potential therapeutic target for the treatment of NSCLC.

頁(從 - 到)75-89
期刊Cancer Research
出版狀態Published - 1 1月 2021


深入研究「Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway」主題。共同形成了獨特的指紋。